The US Food and Drug Administration (FDA) has granted 510(k) approval to B Braun Medical's Introcan Safety 3 Closed IV catheter to protect from needlestick injuries (NSIs).
Introcan Safety 3 features a passive safety needle shield which aids in the prevention of NSIs, multiple access blood control valve to aid in the prevention of blood exposure and integrated stabilization platform to improve catheter stability and minimize movement within the vessel.
The catheter protects clinicians and patients from NSIs as the device cannot be bypassed or activated inadvertently.
B Braun Medical Vascular Access and IV Systems vice president Tom Sutton said the Introcan Safety 3 also provides an added layer of safety and control with a bidirectional blood control valve to aid in the prevention of blood exposure each time the device is accessed.